Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.

Cappellano, Andrea Maria; Petrilli, Antonio Sergio; da Silva, Nasjla Saba; Silva, Frederico Adolfo; Paiva, Priscila Mendes; Cavalheiro, Sergio; Bouffet, Eric

Cappellano, Andrea Maria; Petrilli, Antonio Sergio; da Silva, Nasjla Saba; Silva, Frederico Adolfo; Paiva, Priscila Mendes; Cavalheiro, Sergio; Bouffet, Eric.

Affiliation

Cappellano AM; Pediatric Oncology, IOP-GRAACC/Federal University of São Paulo, Rua Botucatu no 743 - Vila Clementino, São Paulo, 04023-062, Brazil, deacappellano@uol.com.br.

J Neurooncol ; 121(2): 405-12, 2015 Jan.

Article in En | MEDLINE | ID: mdl-25366366

Subject(s)

Antineoplastic Agents, Phytogenic/therapeutic use; Optic Nerve Glioma/drug therapy; Vinblastine/analogs & derivatives; Adolescent; Antineoplastic Agents, Phytogenic/toxicity; Brain/drug effects; Brain/pathology; Brain/radiation effects; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Optic Nerve Glioma/pathology; Optic Nerve Glioma/physiopathology; Optic Nerve Glioma/radiotherapy; Survival Analysis; Treatment Outcome; Vinblastine/therapeutic use; Vinblastine/toxicity; Vinorelbine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vinblastine / Optic Nerve Glioma / Antineoplastic Agents, Phytogenic Type of study: Guideline Aspects: Patient_preference Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Neurooncol Year: 2015 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google